Navigating FDA's approach to approval of nanoparticle-based drugs and devices

被引：0
|
作者：
Duvall, Mark N.
Wyatt, Alexandra M.
Yeung, Felix S.
机构：
来源：
Nanotechnology Law and Business | 2011年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
77
引用
收藏
页码：226 / 244
相关论文
共 50 条
  • [41] All Inorganic Spin-Coated Nanoparticle-Based Capacitive Memory Devices
    Mondal, Sandip
    Venkataraman, V.
    IEEE ELECTRON DEVICE LETTERS, 2016, 37 (04) : 396 - 399
  • [42] Recent advances in magnetic nanoparticle-based microfluidic devices for the pretreatment of pathogenic bacteria
    Han, Hyunsoo
    Sohn, Bokyeong
    Choi, Jihun
    Jeon, Sangmin
    BIOMEDICAL ENGINEERING LETTERS, 2021, 11 (04) : 297 - 307
  • [43] Recent progress in gold nanoparticle-based non-volatile memory devices
    Lee, Jang-Sik
    GOLD BULLETIN, 2010, 43 (03): : 189 - 199
  • [44] Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments
    Pusuluri, Anusha
    Wu, Debra
    Mitragotri, Samir
    JOURNAL OF CONTROLLED RELEASE, 2019, 305 : 130 - 154
  • [45] Nanoparticle-Based Drugs: A Potential Armamentarium of Effective Anti-Cancer Therapies
    Ahmad, Khurshid
    Rabbani, Gulam
    Baig, Mohammad Hassan
    Lim, Jeong Ho
    Khan, Mohammad Ehtisham
    Lee, Eun Ju
    Ashraf, Ghulam Md
    Choi, Inho
    CURRENT DRUG METABOLISM, 2018, 19 (10) : 839 - 846
  • [46] Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy
    Ahmed, Muneeb
    Kumar, Gaurav
    Navarro, Gemma
    Wang, Yuanguo
    Gourevitch, Svetlana
    Moussa, Marwan H.
    Rozenblum, Nir
    Levchenko, Tatyana
    Galun, Eithan
    Torchilin, Vladimir P.
    Goldberg, S. Nahum
    PLOS ONE, 2015, 10 (07):
  • [47] Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems
    Sharma, Arati
    Madhunapantula, SubbaRao V.
    Robertson, Gavin P.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (01) : 47 - 69
  • [48] Quantum of Effectiveness Evidence in FDA's Approval of Orphan Drugs Cataloguing FDA's Flexibility in Regulating Therapies for Persons with Rare Disorders
    Sasinowski, Frank J.
    DRUG INFORMATION JOURNAL, 2012, 46 (02): : 238 - 263
  • [49] IMPORTATION OF DRUGS AND MEDICAL DEVICES IN THE UNITED-STATES - AN OVERVIEW OF FDA PRE-MARKET APPROVAL REQUIREMENTS
    HAMER, RA
    PHARMACY INTERNATIONAL, 1986, 7 (09): : 214 - 219
  • [50] Deciphering the Role of Nanoparticle-based Treatment for Parkinson's Disease
    Moni, Md Marufur Rahman
    Begum, Mst Marium
    Uddin, Md Sahab
    Ashraf, Ghulam Md
    CURRENT DRUG METABOLISM, 2021, 22 (07) : 550 - 560
12345